Tunable Hydrogels with Improved Viscoelastic Properties from Hybrid Polypeptides
Dimitrios Skoulas et al, 2021, Macromolecules CrossRef
Autocrine Extra-Pancreatic Trypsin 3 Secretion Promotes Cell Proliferation and Survival in Esophageal Adenocarcinoma
Song Han et al, 2013, PLoS ONE CrossRef
Protease-activated receptor-2 induces expression of vascular endothelial growth factor and cyclooxygenase-2 via the mitogen-activated protein kinase pathway in gastric cancer cells
CHENG ZHANG et al, 2012, Oncology Reports CrossRef
Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
Kjetil Søreide et al, 2020, Journal of Pancreatic Cancer CrossRef
Proteinase-activated receptor 2 (PAR2) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level
Roland Kaufmann et al, 2012, Histochemistry and Cell Biology CrossRef
A novel peptide-based electrochemical biosensor for the determination of a metastasis-linked protease in pancreatic cancer cells
Cristina Muñoz-San Martín et al, 2020, Analytical and Bioanalytical Chemistry CrossRef
Anti-Tumor Effect of Synthetic Serine Protease Inhibitor
Kenei Furukawa et al, 2013, Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds CrossRef
Molecular Pathogenesis of Cholangiocarcinoma
Peter L. Labib et al, 2019, BMC Cancer CrossRef
PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer
Ruiqiong Ma et al, 2015, Gynecologic Oncology CrossRef
Teleocidin A2 inhibits human proteinase‐activated receptor 2 signaling in tumor cells
Sonja Stahn et al, 2016, Pharmacology Research & Perspectives CrossRef
Proteinase-Activated Receptors (PARs) and Calcium Signaling in Cancer
Roland Kaufmann et al, 2012, Calcium Signaling CrossRef
Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications
TF. Plasse et al, 2023, Expert Opinion on Investigational Drugs CrossRef